💡We need to consider this vaccine—a whole virus traditional one that may add more protection versus variants (watch the🎥 why) & mRNA-vaccine-hesitant folks can be comfortable with. ➡️The FDA should honestly authorize #COVAXIN—EUA app submitted & waiting.
2) Notably, unlike a single target spike protein vaccine line mRNA ones or the adenovirus (J&J and AstraZeneca) ones, an inactivated whole virus traditional vaccine has multiple protein targets for which the body can “learn” to build recognition and immunity if spike is mutated. 
3) P.s. I own **zero** stocks in COVAXIN makers. I’ve never traded their stock.
https://twitter.com/spy_scalper/status/1484230014052749314
4) there’s also really great or proven efficacy, and the only one with proven efficacy against Delta in a phase 3 trial (none of the other US vaccines have Delta efficacy from a trial—only non-randomized real world data).
📍Also key — **zero** myocarditis reported in trials!
📍Also key — **zero** myocarditis reported in trials!
5) 3 months storage at **room temperature** and 2 years in a basic refrigerator. I don’t think any other current FDA approved vaccine can come anywhere near matching that stability.
6) COVAXIN has been patiently waiting since November 5th for its EUA to be approved. FDA is just sitting on it for 2.5 months. It’s getting disgusting the @US_FDA foot dragging now.
https://twitter.com/DrEricDing/status/1469768300620095494
• • •
Missing some Tweet in this thread? You can try to
force a refresh
